The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 Networks
In recent years the functions that the p53 tumor suppressor plays in human biology have been greatly extended beyond “guardian of the genome.” Our studies of promoter response element sequences targeted by the p53 master regulatory transcription factor suggest a general role for this DNA damage and stress-responsive regulator in the control of human Toll-like receptor (TLR) gene expression. The TLR gene family mediates innate immunity to a wide variety of pathogenic threats through recognition of conserved pathogen-associated molecular motifs. Using primary human immune cells, we have examined expression of the entire TLR gene family following exposure to anti-cancer agents that induce the p53 network. Expression of all TLR genes, TLR1 to TLR10, in blood lymphocytes and alveolar macrophages from healthy volunteers can be induced by DNA metabolic stressors. However, there is considerable inter-individual variability. Most of the TLR genes respond to p53 via canonical as well as noncanonical promoter binding sites. Importantly, the integration of the TLR gene family into the p53 network is unique to primates, a recurrent theme raised for other gene families in our previous studies. Furthermore, a polymorphism in a TLR8 response element provides the first human example of a p53 target sequence specifically responsible for endogenous gene induction. These findings—demonstrating that the human innate immune system, including downstream induction of cytokines, can be modulated by DNA metabolic stress—have many implications for health and disease, as well as for understanding the evolution of damage and p53 responsive networks.
Vyšlo v časopise:
The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 Networks. PLoS Genet 7(3): e32767. doi:10.1371/journal.pgen.1001360
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1001360
Souhrn
In recent years the functions that the p53 tumor suppressor plays in human biology have been greatly extended beyond “guardian of the genome.” Our studies of promoter response element sequences targeted by the p53 master regulatory transcription factor suggest a general role for this DNA damage and stress-responsive regulator in the control of human Toll-like receptor (TLR) gene expression. The TLR gene family mediates innate immunity to a wide variety of pathogenic threats through recognition of conserved pathogen-associated molecular motifs. Using primary human immune cells, we have examined expression of the entire TLR gene family following exposure to anti-cancer agents that induce the p53 network. Expression of all TLR genes, TLR1 to TLR10, in blood lymphocytes and alveolar macrophages from healthy volunteers can be induced by DNA metabolic stressors. However, there is considerable inter-individual variability. Most of the TLR genes respond to p53 via canonical as well as noncanonical promoter binding sites. Importantly, the integration of the TLR gene family into the p53 network is unique to primates, a recurrent theme raised for other gene families in our previous studies. Furthermore, a polymorphism in a TLR8 response element provides the first human example of a p53 target sequence specifically responsible for endogenous gene induction. These findings—demonstrating that the human innate immune system, including downstream induction of cytokines, can be modulated by DNA metabolic stress—have many implications for health and disease, as well as for understanding the evolution of damage and p53 responsive networks.
Zdroje
1. HeL
HeX
LoweSW
HannonGJ
2007 microRNAs join the p53 network–another piece in the tumour-suppression puzzle. Nat Rev Cancer 7 819 822
2. HuarteM
GuttmanM
FeldserD
GarberM
KoziolMJ
2010 A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142 409 419
3. JordanJJ
MenendezD
IngaA
NourredineM
BellD
2008 Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. PLoS Genet 4 e1000104 doi:10.1371/journal.pgen.1000104
4. NoureddineMA
MenendezD
CampbellMR
BandeleOJ
HorvathMM
2009 Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts. PLoS Genet 5 e1000462 doi:10.1371/journal.pgen.1000462
5. MenendezD
IngaA
ResnickMA
2010 Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences. Proc Natl Acad Sci U S A 107 1500 1505
6. MenendezD
IngaA
ResnickMA
2009 The expanding universe of p53 targets. Nat Rev Cancer 9 724 737
7. JeggaAG
IngaA
MenendezD
AronowBJ
ResnickMA
2008 Functional evolution of the p53 regulatory network through its target response elements. Proc Natl Acad Sci U S A 105 944 949
8. TomsoDJ
IngaA
MenendezD
PittmanGS
CampbellMR
2005 Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. Proc Natl Acad Sci U S A 102 6431 6436
9. TauraM
EgumaA
SuicoMA
ShutoT
KogaT
2008 p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. Mol Cell Biol 28 6557 6567
10. PalmNW
MedzhitovR
2009 Pattern recognition receptors and control of adaptive immunity. Immunol Rev 227 221 233
11. BauerS
MullerT
HammS
2009 Pattern recognition by Toll-like receptors. Adv Exp Med Biol 653 15 34
12. GarantziotisS
HollingsworthJW
ZaasAK
SchwartzDA
2008 The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59 343 359
13. HennessyEJ
ParkerAE
O'NeillLA
2010 Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9 293 307
14. IwasakiA
MedzhitovR
2010 Regulation of adaptive immunity by the innate immune system. Science 327 291 295
15. ArmstrongL
MedfordAR
HunterKJ
UppingtonKM
MillarAB
2004 Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 136 312 319
16. Komai-KomaM
JonesL
OggGS
XuD
LiewFY
2004 TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A 101 3029 3034
17. HarterL
MicaL
StockerR
TrentzO
KeelM
2004 Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22 403 409
18. HayashiF
MeansTK
LusterAD
2003 Toll-like receptors stimulate human neutrophil function. Blood 102 2660 2669
19. Kurt-JonesEA
MandellL
WhitneyC
PadgettA
GosselinK
2002 Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100 1860 1868
20. MuzioM
BosisioD
PolentaruttiN
D'AmicoG
StoppacciaroA
2000 Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164 5998 6004
21. CorreaCR
CheungVG
2004 Genetic variation in radiation-induced expression phenotypes. Am J Hum Genet 75 885 890
22. LevineAJ
1997 p53, the cellular gatekeeper for growth and division. Cell 88 323 331
23. VassilevLT
VuBT
GravesB
CarvajalD
PodlaskiF
2004 In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 844 848
24. KomarovPG
KomarovaEA
KondratovRV
Christov-TselkovK
CoonJS
1999 A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285 1733 1737
25. el-DeiryWS
KernSE
PietenpolJA
KinzlerKW
VogelsteinB
1992 Definition of a consensus binding site for p53. Nat Genet 1 45 49
26. RileyT
SontagE
ChenP
LevineA
2008 Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9 402 412
27. MenendezD
IngaA
ResnickMA
2006 The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. Mol Cell Biol 26 2297 2308
28. DesleeG
WoodsJC
MooreC
ConradiSH
GieradaDS
2009 Oxidative damage to nucleic acids in severe emphysema. Chest 135 965 974
29. IshidaT
HironoY
YoshikawaK
HuteiY
MiyagawaM
2009 Inhibition of immunological function mediated DNA damage of alveolar macrophages caused by cigarette smoke in mice. Inhal Toxicol 21 1229 1235
30. MengZ
ZhangQ
2007 Damage effects of dust storm PM2.5 on DNA in alveolar macrophages and lung cells of rats. Food Chem Toxicol 45 1368 1374
31. PasareC
MedzhitovR
2005 Control of B-cell responses by Toll-like receptors. Nature 438 364 368
32. SchnareM
BartonGM
HoltAC
TakedaK
AkiraS
2001 Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2 947 950
33. EspinosaJM
VerdunRE
EmersonBM
2003 p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 12 1015 1027
34. GomesNP
EspinosaJM
2010 Differential regulation of p53 target genes: it's (core promoter) elementary. Genes Dev 24 111 114
35. MenendezD
KrysiakO
IngaA
KrysiakB
ResnickMA
2006 A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc Natl Acad Sci U S A 103 1406 1411
36. YanJ
MenendezD
YangXP
ResnickMA
JettenAM
2009 A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage. J Biol Chem 284 19280 19289
37. HussainSP
AmstadP
HeP
RoblesA
LupoldS
2004 p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64 2350 2356
38. LiuB
ChenY
St ClairDK
2008 ROS and p53: a versatile partnership. Free Radic Biol Med 44 1529 1535
39. JiangD
LiangJ
FanJ
YuS
ChenS
2005 Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11 1173 1179
40. ZhangQ
RaoofM
ChenY
SumiY
SursalT
2010 Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464 104 107
41. BurdelyaLG
KrivokrysenkoVI
TallantTC
StromE
GleibermanAS
2008 An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320 226 230
42. Cherfils-ViciniJ
PlatonovaS
GillardM
LauransL
ValidireP
2010 Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest 120 1285 1297
43. WestbrookAM
WeiB
BraunJ
SchiestlRH
2009 Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res 69 4827 4834
44. ShaoL
FujiiH
ColmegnaI
OishiH
GoronzyJJ
2009 Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med 206 1435 1449
45. KanzlerH
BarratFJ
HesselEM
CoffmanRL
2007 Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13 552 559
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 3
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Whole-Exome Re-Sequencing in a Family Quartet Identifies Mutations As the Cause of a Novel Skeletal Dysplasia
- Origin-Dependent Inverted-Repeat Amplification: A Replication-Based Model for Generating Palindromic Amplicons
- FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
- Limited dCTP Availability Accounts for Mitochondrial DNA Depletion in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)